- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/64 - Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
Patent holdings for IPC class A61K 47/64
Total number of patents in this class: 6676
10-year publication summary
|
312
|
566
|
657
|
732
|
709
|
813
|
774
|
743
|
721
|
342
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20720 |
113 |
| Bicyclerd Limited | 155 |
84 |
| Pfizer Inc. | 3384 |
66 |
| Mayo Foundation for Medical Education and Research | 3382 |
62 |
| Massachusetts Institute of Technology | 10239 |
60 |
| Glaxosmithkline Biologicals S.A. | 1601 |
58 |
| Sarepta Therapeutics, Inc. | 387 |
57 |
| Yale University | 2527 |
51 |
| Purdue Research Foundation | 3913 |
47 |
| Bicycletx Limited | 188 |
45 |
| The Board of Trustees of the Leland Stanford Junior University | 6644 |
41 |
| Ohio State Innovation Foundation | 2366 |
39 |
| Entrada Therapeutics, Inc. | 85 |
38 |
| Bristol-myers Squibb Company | 4729 |
37 |
| The Johns Hopkins University | 5875 |
37 |
| Northwestern University | 3540 |
37 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2999 |
37 |
| Sapreme Technologies B.V. | 98 |
32 |
| Oxford University Innovation Limited | 1658 |
30 |
| Board of Regents, The University of Texas System | 6102 |
29 |
| Other owners | 5676 |